Studies have shown that SARS-CoV-2 elevated inflammation and activates NLRP3 inflammasome, this leads to a cytokine storm and destructive inflammation and Causes ALI/ARDS in patients with COVID-19. The gene discussed is NLRP3; the disease is COVID-19.